Physician profile
Dustin Reynolds
NPI 1801241757
$61,178.90
in general payments reported to CMS, 2019-2025
22 companies · $37K in 2025
The $37K reported for 2025 was more than what 98% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $43.60 · 2021: $1,263 · 2022: $5,566 · 2023: $9,649 · 2024: $7,409 · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $17K · Travel and Lodging: $16K · Consulting Fee: $11K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Entertainment: $21.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16,867.81 |
| Travel and Lodging | $16,407.91 |
| Consulting Fee | $10,798.92 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,210.63 |
| Entertainment | $21.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33,784.35 | 2020-2025 | Proclaim, Eterna, Infinity |
| Medtronic, INC. | $15,295.72 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Dbs |
| Saluda Medical Americas, INC. | $5,698.73 | 2024-2025 | Evoke |
| Relievant Medsystems, INC. | $1,179.14 | 2022-2023 | Intracept |
| Nalu Medical, INC. | $1,106.82 | 2022-2024 | Nalu Neurostimulation System |
| Nevro Corp. | $882.11 | 2021-2024 | Senza |
| Boston Scientific Corporation | $650.82 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept |
| Si-Bone, INC. | $475.15 | 2022-2025 | |
| Stimwave Technologies Incorporated | $426.73 | 2021-2022 | |
| Mml US, INC. | $299.09 | 2025 | Reactiv8 |
| Globus Medical, INC. | $222.76 | 2025 | Senza |
| Curonix LLC | $203.42 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $166.75 | 2025 | Ha Minuteman G3-R |
| Cdc Medical LLC | $156.08 | 2023 | |
| Stryker Corporation | $144.07 | 2025 | Optablate |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik Nro, INC. | $139.77 | 2025 | Prospera |
| Vertex Pharmaceuticals Incorporated | $137.67 | 2025 | |
| Spr Therapeutics, INC | $90.51 | 2021-2022 | |
| Pacira Therapeutics, INC. | $38.83 | 2021 | |
| Vertos Medical, INC. | $31.48 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $27.23 | 2024 | Iovera, Exparel, Zilretta |
| Argentum Medical | $21.67 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.